Management of Coagulopathy in Dengue Fever

Diagnostic Considerations

• The American College of Cardiology recommends maintaining hemoglobin ≥7 g/dL with packed RBC transfusion in patients with active bleeding, considering ≥8 g/dL if coronary artery disease is present 1
• Markedly elevated D-dimer levels (3-4× normal) indicate increased thrombin generation and worse prognosis in dengue fever patients, according to the Journal of Thrombosis and Haemostasis 2, 3, 4

Management of Active Bleeding

• The American College of Cardiology suggests aggressive volume resuscitation with isotonic crystalloids to restore hemodynamic stability in patients with active bleeding 1
• Critical Care recommends transfusing platelets if the count is <25 × 10⁹/L with active bleeding 5
• Fresh frozen plasma should be considered if INR >2.0 with active bleeding and fibrinogen <0.5 g/L, as per Critical Care 5
• Target fibrinogen >2.0 g/L in bleeding patients, according to the Journal of Thrombosis and Haemostasis 2, 3

Prognostic Factors

• Mild PT/PTT prolongation (PT 12-16 seconds, PTT 30-45 seconds) is common and does not require correction in non-bleeding patients, as stated in the Journal of Thrombosis and Haemostasis 2, 3, 4
• D-dimer or coagulation parameters alone should not be used to guide anticoagulation decisions outside clinical trial settings, according to Critical Care 6

Coagulopathy in Dengue Fever

Pathophysiological Mechanisms

• Liver dysfunction affects the synthesis of coagulation factors in dengue patients, contributing to coagulopathy 7
• Development of disseminated intravascular coagulation (DIC) occurs in severe cases of dengue, further complicating coagulopathy 8

Temporal Pattern and Resolution

• Initial prolongation of aPTT occurs during the early acute phase of dengue infection, with aPTT abnormalities following a predictable pattern 7
• The normalization of aPTT during recovery correlates with rising platelet counts in dengue patients 8

Contributing Factors

• The presence of lupus anticoagulant antibodies can cause aPTT prolongation in dengue patients, although this mechanism is less established 7

Monitoring and Management Implications

• Regular monitoring of aPTT, along with other coagulation parameters, is essential in evaluating coagulopathy severity in dengue patients 8
• Concurrent medication use, such as anticoagulants or antiplatelets, should be considered when interpreting aPTT in dengue patients 7